Fredun Pharmaceuticals Limited at the Board of Directors meeting held on May 24, 2023, recommended final dividend at 7% per equity share having face value of INR 10 each for the financial year 2022-23; subject to the approval of the Shareholders at the upcoming Annual General Meeting of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
870.4 INR | -1.02% | +4.13% | +0.18% |
10/05 | Fredun Pharmaceuticals Limited Proposes Final Dividend for the Financial Year 2023-24 | CI |
08/05 | Fredun Pharmaceuticals' Net Profit Jumps in Fiscal Q4; Shares Dip 9% | MT |
1st Jan change | Capi. | |
---|---|---|
+0.18% | 4.95Cr | |
+32.09% | 69TCr | |
+29.39% | 59TCr | |
-1.34% | 37TCr | |
+20.34% | 33TCr | |
+7.39% | 29TCr | |
+14.25% | 24TCr | |
-3.03% | 21TCr | |
+10.02% | 21TCr | |
+8.49% | 17TCr |
- Stock Market
- Equities
- FREDUN6 Stock
- News Fredun Pharmaceuticals Limited
- Fredun Pharmaceuticals Limited Recommends Final Dividend for the Financial Year 2022-23